The effect of BCL11A gene (rs766432) and HBS1L-MYB gene (rs9399137) polymorphism on beta thalassemia in Iraqi patients

Abstract Background β-Thalassemia is a serious genetic disorder with an extensive range of clinical phenotypes ranging from asymptomatic to symptomatic disease depending on times of blood transfusions, this genetic disorder is highly distributed globally and regionally so the ability to predict the severity of the disease is crucial for management and treatment, the severity of thalassemia is variable from mild, moderate to severe according to many factors one of them is the different ethnicity which may have different allele frequency and linkage disequilibrium structures. This study is the first study in Iraq that collect the two different single nucleotide polymorphisms (SNPs) rs766432 and rs9399137 in two different genes BCL11A and HBS1L-MYB to show their effect on thalassemia. Methods 200 individuals were enrolled in this study to show the effect of two different SNPs rs766432 and rs9399137 in two different genes BCL11A and HBS1L-MYB respectively on the severity of β-Thalassemia in patient comparing with healthy individuals, also to determine their effect on the levels of haemoglobin. Results This study show a significant results for rs9399137 in HBS1L-MYB gene with 1.82 fold, a significant results in rs766432 in BCL11A gene with 1.92 fold when compared between patient and control, also there is a significant results for rs9399137 in HBS1L-MYB gene with 2.10, 1.7 fold, a significant results in rs766432 in BCL11A gene with 2.15, 2.10 fold when compared between male and female, there is a significant results for rs9399137 in HBS1L-MYB gene with 2.55, 1.87 fold, a significant results in rs766432 in BCL11A gene with 2.65, 1.62 fold according to age, finally, there is there is a significant results for rs9399137 in HBS1L-MYB gene with 1.52, 1.28 fold, a significant results in rs766432 in BCL11A gene with 1.7, 1.34, fold according to the level of hemoglobin (HB). Conclusions BCL11A Gene (rs766432) and HBS1L-MYB Gene (rs9399137) polymorphisms were strongly associated with the development of thalassemia in Iraqi population.

Authors

Institutions

Publication Details

Journal
Egyptian Journal of Medical Human Genetics
Published
2025-12-30
DOI
https://doi.org/10.1186/s43042-025-00824-2
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of BCL11A gene (rs766432) and HBS1L-MYB gene (rs9399137) polymorphism on beta thalassemia in Iraqi patients

Haider Farhan Salman, Laith A. Younus, Ahmed Hassan Khudair, Khalid Hassan Abdulrudha et al.
Egyptian Journal of Medical Human Genetics
Hemoglobinopathies and Related Disorders
article

The effect of BCL11A gene (rs766432) and HBS1L-MYB gene (rs9399137) polymorphism on beta thalassemia in Iraqi patients

Haider Farhan Salman, Laith A. Younus, Ahmed Hassan Khudair, Khalid Hassan Abdulrudha, Fadhil Abass Nasser
article en

Abstract

Abstract Background β-Thalassemia is a serious genetic disorder with an extensive range of clinical phenotypes ranging from asymptomatic to symptomatic disease depending on times of blood transfusions, this genetic disorder is highly distributed globally and regionally so the ability to predict the severity of the disease is crucial for management and treatment, the severity of thalassemia is variable from mild, moderate to severe according to many factors one of them is the different ethnicity which may have different allele frequency and linkage disequilibrium structures. This study is the first study in Iraq that collect the two different single nucleotide polymorphisms (SNPs) rs766432 and rs9399137 in two different genes BCL11A and HBS1L-MYB to show their effect on thalassemia. Methods 200 individuals were enrolled in this study to show the effect of two different SNPs rs766432 and rs9399137 in two different genes BCL11A and HBS1L-MYB respectively on the severity of β-Thalassemia in patient comparing with healthy individuals, also to determine their effect on the levels of haemoglobin. Results This study show a significant results for rs9399137 in HBS1L-MYB gene with 1.82 fold, a significant results in rs766432 in BCL11A gene with 1.92 fold when compared between patient and control, also there is a significant results for rs9399137 in HBS1L-MYB gene with 2.10, 1.7 fold, a significant results in rs766432 in BCL11A gene with 2.15, 2.10 fold when compared between male and female, there is a significant results for rs9399137 in HBS1L-MYB gene with 2.55, 1.87 fold, a significant results in rs766432 in BCL11A gene with 2.65, 1.62 fold according to age, finally, there is there is a significant results for rs9399137 in HBS1L-MYB gene with 1.52, 1.28 fold, a significant results in rs766432 in BCL11A gene with 1.7, 1.34, fold according to the level of hemoglobin (HB). Conclusions BCL11A Gene (rs766432) and HBS1L-MYB Gene (rs9399137) polymorphisms were strongly associated with the development of thalassemia in Iraqi population.

Egyptian Journal of Medical Human GeneticsVol. 26(1)
University of Alkafeel (IQ), University of Kufa (IQ)
Openalex Percentile: Top 25%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.